Home | Recruitment

Recruiting

Trials by recruitment status

Public Titlesort icon Date of registration Sponsor
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. 2010-12-17 CIM
Nimotuzumab in tumors of head and neck .Phase IV 2013-02-01 CIMAB
Nimotuzumab-pancreatic cancer-adults-Phase IV. 30/04/2017 CIM
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers 2013-02-08 CIGB
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. 2010-09-27 CIGB
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. 23/05/2014 CIM
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. 2009-02-11 CIGB
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION 03/07/2020 IHI
Pneumococcal conjugate vaccination among Warao children 2013-06-14 SAIB
Predictor of response with CIMAvax EGF© in NSCLC Phase III 29/01/2016 CIM
PrevengHo-Vir Homeoprohylaxis COVID-2019 13/05/2020 MINSAP_MNT
Racotumomab,Nimotuzumab or Docetaxel in the treatment of the advanced non-small cell lung cancer. 26/05/2014 CIM
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma 05/11/2013 CIM
rTMS-stroke-phase I 2009-05-29 CIREN
Safety and effectiveness of SURFACEN® combined with the conventional therapy, in the treatment of ARDS in pediatrics. National extension 29/09/2017 CENSA
SOBERANA 01 13/08/2020 FINLAY
SOBERANA PEDIATRIA CLINICA 1 23/07/2021 FINLAY
Stem cell assisted centrifugal fat transfer 26/03/2021 HHA
Stem cells in patients with lung lesions (COVID-19) 03/07/2020 IHI
Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II 14/06/2018 BIOCEN